Professor Mojisola Christianah Adeyeye was appointed the Director-General of NAFDAC on the 3rd of November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari. She was the founding Chair of Biopharmaceutical Sciences and a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation at the College of Pharmacy, Roosevelt University in Schaumburg, Illinois, where she spent 7 years. She was Professor of Pharmaceutics and Manufacturing for 21 years at Duquesne University in Pittsburgh, Pennsylvania , USA. She is Senior Fulbright Scholar and Specialist and 2008 American Association of Pharmaceutical Scientists Fellow (the first African woman fellow). She is also a Fellow of the Nigerian Academy of Science and Nigeria Academy of Pharmacy. Her research interests include pre-formulation, early phase development of solid, semisolid and liquid dosage forms, and IND-based and intellectual property-driven late phase drug product development. She has supervised numerous PhD and M.S candidates. With 6 patents, over 60 peer-reviewed manuscripts, book chapters and books, she has more than 150 scientific presentations. She is the founder and President of a socially conscious start-up company – Elim Pediatric Pharmaceuticals Rolling Meadows, IL.^[1] Through Duquesne University, she developed an anti-retroviral (HIV/AIDS) pediatric fixed dose combination and received intellectual property on the formulations in the UK and South Africa.^[2]

Background

Education

Prof. Moji Adeyeye attended the University of Nigeria, Nsukka, obtaining a Bachelor's degree in Pharmaceutics in 1976. She proceeded the University of Georgia and obtained M.S in Pharmaceutics in 1985 and a PhD in 1988 from same institution.^[3]

Career

Moji Adeyeye started her career as a Pharmacist at the University College Hospital, Ibadan, Oyo State, Nigeria in 1976 and remained there till 1979. She proceeded to head the Pharmacy department at the Baptist Hospital, Ogbomoso, Oyo State, Nigeria in 1979 to 1980. She started her academic career in 1988 as an Assistant Professor at the School of Pharmacy, University of Puerto Rico, San Juan, Puerto Rico and proceeded to Duquesne University, Pittsburgh, Pennsylvania as an Assistant Professor in 1989 and was promoted to the rank of Associate Professor in 1994 in the same institution. In 2003, she was promoted to the rank of Professor of Pharmaceutics and Pharmaceutical Technology, Division of Pharmaceutical Sciences, School of Pharmacy in the same University and remained there till 2010. in 2010, she was appointed Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation, College of Pharmacy, Roosevelt University, Schaumburg, IL till 2018. She was the Chair, Department of Biopharmaceutical Sciences, College of Pharmacy, Roosevelt University from 2010 to 2017. From 2004 to date, Prof Moji Adeyeye has been the President, Drugs for AIDS and HIV Patients (DAHP) - a faith based tax-exempt organization with the aim of preventing HIV/AIDS among Nigerian youths as well as prevention of mother-to-child transmission and care for orphans and vulnerable children in Lagos, Osun and Oyo States. She is President, Drugs for AIDS and HIV Patients (DAHP), a position she has held since 2004. From 2004 to 2005, she was a Senior Fulbright Scholar, Faculty of Pharmacy, University of Lagos and National Institute for Pharmaceutical Research and Development, Abuja, Nigeria.

^{[4] [5]}